Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:12 PM
Ignite Modification Date:
2025-12-24 @ 9:12 PM
NCT ID:
NCT05492604
Eligibility Criteria:
Inclusion Criteria:
* Patients of both sexes, aged 18 to 75 years old.
* Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) defined or probable according to the EFNS/PNS (European Federation of Neurological Societies/Peripheral Nerve Society) diagnostic criteria proposed in 2010.
* Patients treated with intravenous polyvalent immunoglobulins.
* Patients with gait impairment related to CIDP, not requiring technical assistance, with an ONLS (Overall Neuropathy Limitations Scale) score of 1 or 2/7 on the lower limbs at inclusion.
* Patients affiliated to or benefiting from a social security scheme.
* Patients giving their free and informed consent to participate after information about the research.
Exclusion Criteria:
* Pregnant or breastfeeding women.
* Patients placed under guardianship, curatorship or safeguard of justice.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05492604
Study Brief:
Protocol Section:
NCT05492604